Why the study?
Management of takotsubo syndrome is currently empirical and supportive due to elusive pathophysiology, prompting a review of acute and follow-up management principles and potential therapeutic hypotheses.
Design
Review
Authors
Loading...
Hypothesis-generating for insulin-beta-blocker combinations in takotsubo syndrome; prospective trials required before any clinical consideration.
This review summarizes current empirical management strategies for takotsubo syndrome and introduces novel therapeutic hypotheses for future investigation.
John E. Madias (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: